Literature DB >> 20179186

Bone sarcomas: Overview of management, with a focus on surgical treatment considerations.

Steven A Lietman1, Michael J Joyce.   

Abstract

Outcomes for patients with bone sarcomas have improved dramatically over the past 40 years, and most bone sarcomas today are treated with surgery and chemotherapy. The most common clinical findings in patients with bone sarcomas are pain and an enlarging bone mass, although pain is not generally a good indicator of malignancy. In general, any patient with a bone mass with indeterminate imaging findings should be referred to an orthopedic oncologist. Bone sarcomas are diagnosed after a biopsy, which is best performed by the surgeon who will be doing the curative resection. Postresection reconstruction of the affected limb is generally done with an allograft-prosthetic composite or a modular metallic prosthetic joint replacement device. Post-therapy follow-up at frequent and regular intervals is critical to assess for recurrence and lung metastasis.

Entities:  

Mesh:

Year:  2010        PMID: 20179186     DOI: 10.3949/ccjm.77.s1.02

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  15 in total

Review 1.  State-of-the-art approach for bone sarcomas.

Authors:  Andreas F Mavrogenis; Andrea Angelini; Christos Vottis; Emanuela Palmerini; Eugenio Rimondi; Giuseppe Rossi; Panayiotis J Papagelopoulos; Pietro Ruggieri
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-05-03

2.  A retrospective statistical analysis of high-grade soft tissue sarcomas.

Authors:  Gregory G Kolovich; Adam N Wooldridge; Jonathan M Christy; Martha K Crist; Joel L Mayerson; Thomas J Scharschmidt
Journal:  Med Oncol       Date:  2011-05-07       Impact factor: 3.064

Review 3.  Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.

Authors:  Xing Dai; Wei Ma; Xijing He; Rajiv Kumar Jha
Journal:  Med Sci Monit       Date:  2011-08

4.  Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.

Authors:  Joeri Both; Thijs Wu; Johannes Bras; Gerard R Schaap; Frank Baas; Theo J M Hulsebos
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

5.  CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice.

Authors:  Patrick Brennecke; Matthias J E Arlt; Carmen Campanile; Knut Husmann; Ana Gvozdenovic; Tiziana Apuzzo; Marcus Thelen; Walter Born; Bruno Fuchs
Journal:  Clin Exp Metastasis       Date:  2014-01-04       Impact factor: 5.150

Review 6.  Spinal osteosarcoma.

Authors:  P Katonis; G Datsis; A Karantanas; A Kampouroglou; S Lianoudakis; S Licoudis; E Papoutsopoulou; K Alpantaki
Journal:  Clin Med Insights Oncol       Date:  2013-08-18

7.  GRM4 gene polymorphism is associated with susceptibility and prognosis of osteosarcoma in a Chinese Han population.

Authors:  Chaoyin Jiang; Hua Chen; Lei Shao; Yang Dong
Journal:  Med Oncol       Date:  2014-07       Impact factor: 3.064

8.  Inactivated autograft-prosthesis composite has a role for grade III giant cell tumor of bone around the knee.

Authors:  SongFeng Xu; XiuChun Yu; Ming Xu; ZhiHou Fu
Journal:  BMC Musculoskelet Disord       Date:  2013-11-09       Impact factor: 2.362

9.  The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.

Authors:  Christina Baldauf; Anke Jeschke; Vincent Kanbach; Philip Catala-Lehnen; Daniel Baumhoer; Helwe Gerull; Sophia Buhs; Michael Amling; Peter Nollau; Sheila Harroch; Thorsten Schinke
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

Review 10.  Neoplasm seeding in biopsy tract of the musculoskeletal system. A systematic review.

Authors:  Marcelo Parente Oliveira; Pablo Moura de Andrade Lima; Hilton Justino da Silva; Roberto José Vieira de Mello
Journal:  Acta Ortop Bras       Date:  2014       Impact factor: 0.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.